Alpha thalassemia genotypes in Kuwait

Affiliations


Abstract

Background: The frequency of the alpha thalassemia trait is approximately 40% in the Kuwaiti population, but there has been no comprehensive study of the prevalent alleles. This is a report of patients who were referred for molecular diagnosis over a 20-year period.

Methods: This is a retrospective study of the α-globin genotypes obtained in the Hemoglobin Research Laboratory of the Department of Pediatrics, Kuwait University from 1994 to 2015. Genotyping was performed by a combination of PCR, allele-specific oligonucleotide hybridization and reverse dot blot hybridization (Vienna Lab Strip Assay).

Results: Four hundred samples were characterized and analyzed from individuals aged < 1 month to 80 years, with a median of 6 years from 283 unrelated families. Most (90.8%) were Kuwaiti nationals. The commonest genotype was homozygosity for the polyadenylation-1 mutation (αPA-1α/α PA-1α) in 33.3% of the samples, followed by heterozygosity (αα/α PA-1α) for the same mutation in 32.3%. PA-1 was therefore the most frequent allele (0.59). The frequency of the α0 (--MED) allele was 0.017. Rare alleles that were found in very low frequencies included α0 (--FIL) in a Filipino child, Hb Constant Spring, Hb Adana, and Hb Icaria.

Conclusion: There is a wide variety of alpha thalassemia alleles among Kuwaitis, but nondeletional PA-1 is by far the most common cause of the moderate to severe HbH (β4 tetramer) disease phenotype. The α0 (-MED) allele is also encountered, which has implications for premarital counseling, especially for the possibility of having babies with alpha thalassemia major (Barts hydrops fetalis).

Keywords: Alpha thalassemia; Hemoglobin H disease; Kuwait.

Conflict of interest statement

There are no other competing financial or nonfinancial interests.


Similar articles

Evaluation of Alpha-Thalassemia Mutations in Cases with Hypochromic Microcytic Anemia: The İstanbul Perspective.

Karakaş Z, Koç B, Temurhan S, Elgün T, Karaman S, Asker G, Gençay G, Timur Ç, Yıldırmak ZY, Celkan T, Devecioğlu Ö, Aydın F.Turk J Haematol. 2015 Dec;32(4):344-50. doi: 10.4274/tjh.2014.0204. Epub 2015 Aug 6.PMID: 26377141 Free PMC article.

α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.

Al-Riyami AZ, Daar S, Kindi SA, Madhani AA, Wali Y, Rawahi MA, Zadjali SA.Hemoglobin. 2020 Jan;44(1):20-26. doi: 10.1080/03630269.2020.1720709. Epub 2020 Feb 5.PMID: 32019385

Genotype-phenotype correlation of HbH disease in northern Iraq.

Shamoon RP, Yassin AK, Polus RK, Ali MD.BMC Med Genet. 2020 Oct 15;21(1):203. doi: 10.1186/s12881-020-01141-8.PMID: 33059634 Free PMC article.

Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.

Henderson SJ, Timbs AT, McCarthy J, Gallienne AE, Proven M, Rugless MJ, Lopez H, Eglinton J, Dziedzic D, Beardsall M, Khalil MS, Old JM.Hemoglobin. 2016;40(2):75-84. doi: 10.3109/03630269.2015.1113990. Epub 2015 Dec 4.PMID: 26635043 Review.

Hb H disease: clinical course and disease modifiers.

Fucharoen S, Viprakasit V.Hematology Am Soc Hematol Educ Program. 2009:26-34. doi: 10.1182/asheducation-2009.1.26.PMID: 20008179 Review.


Cited by

Genotype-phenotype correlation in patients with deletional and nondeletional mutations of Hb H disease in Southwest of Iran.

Hamid M, Keikhaei B, Galehdari H, Saberi A, Sedaghat A, Shariati G, Mohammadi-Anaei M.Sci Rep. 2022 Mar 22;12(1):4856. doi: 10.1038/s41598-022-08986-4.PMID: 35319015 Free PMC article.


KMEL References


References

  1.  
    1. Piel FB, Weatherall DJ. The alpha-thalassemias. N Engl J Med. 2014;371(20):1908–1916. - PubMed
  2.  
    1. Adekile AD, Liu JC, Sulzer AJ, Huisman TH. Frequency of the alpha-thalassemia-2 gene among Nigerian SS patients and its influence on malaria antibody titers. Hemoglobin. 1993;17(1):73–79. - PubMed
  3.  
    1. White JM, Byrne M, Richards R, Buchanan T, Katsoulis E, Weerasingh K. Red cell genetic abnormalities in peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia. J Med Genet. 1986;23(3):245–251. - PMC - PubMed
  4.  
    1. White JM, Byrne M, Richards R, Buchanan T, Sheik-Yousouf I, White YS, Frost B. Thalassaemia genes in peninsular Arabs. Br J Haematol. 1985;60(2):269–278. - PubMed
  5.  
    1. Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program. 2009;(1):26–34. - PubMed
  6.  
    1. Vichinsky EP. Clinical manifestations of alpha-thalassemia. Cold Spring Harbor perspectives in medicine. 2013;3(5):a011742. - PMC - PubMed
  7.  
    1. Harteveld CL, Losekoot M, Haak H, Heister GA, Giordano PC, Bernini LF. A novel polyadenylation signal mutation in the alpha 2-globin gene causing alpha thalassaemia. Br J Haematol. 1994;87(1):139–143. - PubMed
  8.  
    1. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010;5:13. - PMC - PubMed
  9.  
    1. Hall GW, Higgs DR, Murphy P, Villegas A, de Miguel A. A mutation in the polyadenylation signal of the alpha 2 globin gene (AATAAA-->AATA--) as a cause of alpha thalassaemia in Asian indians. Br J Haematol. 1994;88(1):225–227. - PubMed
  10.  
    1. Higgs DR, Goodbourn SE, Lamb J, Clegg JB, Weatherall DJ, Proudfoot NJ. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature. 1983;306(5941):398–400. - PubMed
  11.  
    1. Yuregir GT, Aksoy K, Curuk MA, Dikmen N, Fei YJ, Baysal E, Huisman TH. Hb H disease in a Turkish family resulting from the interaction of a deletional alpha-thalassaemia-1 and a newly discovered poly a mutation. Br J Haematol. 1992;80(4):527–532. - PubMed
  12.  
    1. Clegg JB, Weatherall DJ, Contopolou-Griva I, Caroutsos K, Poungouras P, Tsevrenis H. Haemoglobin Icaria, a new chain-termination mutant with causes alpha thalassaemia. Nature. 1974;251(5472):245–247. - PubMed
  13.  
    1. Clegg JB, Weatherall DJ, Milner PF. Haemoglobin constant spring--a chain termination mutant? Nature. 1971;234(5328):337–340. - PubMed
  14.  
    1. De Jong WW, Meera Khan P, Bernini LF. Hemoglobin Koya Dora: high frequency of a chain termination mutant. Am J Hum Genet. 1975;27(1):81–90. - PMC - PubMed
  15.  
    1. Haider M, Adekile A. Alpha-2-globin gene polyadenylation (AATAAA-->AATAAG) mutation in hemoglobin H disease among Kuwaitis. Med Princ Pract. 2005;14(Suppl 1):73–76. - PubMed
  16.  
    1. Adekile AD, Azab AF, Al-Sharida SI, Al-Nafisi BA, Akbulut N, Marouf RA, Mustafa NY. Clinical and molecular characteristics of non-transfusion-dependent thalassemia in Kuwait. Hemoglobin. 2015;39(5):320–326. - PubMed
  17.  
    1. Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193–211. - PubMed
  18.  
    1. Baysal E, Huisman T. Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46:208–213. - PubMed
  19.  
    1. Adekile AD, Haider MZ. Morbidity, beta S haplotype and alpha-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol. 1996;96(3):150–154. - PubMed
  20.  
    1. Gilad O, Shemer OS, Dgany O, Krasnov T, Nevo M, Noy-Lotan S, Rabinowicz R, Amitai N, Ben-Dor S, Yaniv I, et al. Molecular diagnosis of alpha-thalassemia in a multiethnic population. Eur J Haematol. 2017;98(6):553–562. - PubMed
  21.  
    1. Al-Awamy BH. Thalassemia syndromes in Saudi Arabia. Meta-analysis of local studies. Saudi Med J. 2000;21(1):8–17. - PubMed
  22.  
    1. Abu-Ghoush M. Subtypes of alpha thalassemia diagnosed at a medical center in Jordan. TAF Prev Med Bull. 2008;7(5):373–376.
  23.  
    1. Jassim N, Al-Arrayed S, Gerard N, Al-Mukharraq H, Al-Ajami A, Ducrocoq R, Nagel R. R K: Molecular Basis of α-Thalassemia in Bahrain. Bahrain Medical Bulletin. 2001;23(1):3–7.
  24.  
    1. El-Kalla S, Baysal E. alpha-thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49–53. - PubMed